Skip to search formSkip to main contentSkip to account menu

lanreotide acetate

Known as: L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide, acetate 
The acetate salt of a synthetic cyclic octapeptide analogue of somatostatin. Lanreotide binds to somatostatin receptors (SSTR), specifically SSTR-2… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
PurposePeptide drugs for antineoplastic therapies usually have low oral bioavailability and short in vivo half-lives, requiring… 
Review
2014
Review
2014
Lanreotide Autogel® (ATG) [Somatuline® Autogel®, Somatuline® Depot®] is a prolonged-release, supersaturated aqueous gel… 
2012
2012
The goal of this project was to prepare long-acting lanreotide acetate poly(lactic-co-glycolic acid) (PLGA) microspheres and to… 
2012
2012
SummaryAbstract|Lanreotide Autogel® (ATG) [Somatuline® Depot] is a novel, long-acting preparation of the somatostatin analogue… 
Highly Cited
2011
Highly Cited
2011
CONTEXT Congenital hyperinsulinism (CH) may be treated conservatively in many children with octreotide given by multiple sc… 
Review
2008
Review
2008
Lanreotide Autogel (ATG) [Somatuline Depot] is a novel, long-acting preparation of the somatostatin analogue lanreotide acetate… 
2003
2003
PURPOSE We evaluated whether a combination therapy of ethinylestradiol and somatostatin analogue can reintroduce objective… 
2001
2001
Cystic dystrophy in heterotopic pancreas of the duodenal wall is a rare but benign disease, associated in most of the cases with…